Dr.ย Je-Hwanย Lee
MD, PhD
Professor in Hematology
corporate_fareAsan Medical Center, Seoul, South Korea
Je-Hwan Lee
MD, PhD
Prof. Je-Hwan Lee is a senior hematologist and academic physician at Asan Medical Center, Seoul, one of South Korea's foremost tertiary cancer institutions. He practises within the Department of Hematology, AMC Cancer Institute, and the Hematologic Cancer & BMT Centre, where his clinical work centres on leukaemia, myelodysplastic syndrome, haematopoietic stem cell transplantation, blood diseases, and cell therapy.
Prof. Lee has progressed through every academic rank at the University of Ulsan College of Medicine and Asan Medical Center, from Clinical Instructor through to Professor in Hematology. His research output spans AML chemotherapy intensity, transplant conditioning strategies, autologous and allogeneic haematopoietic cell transplantation, high-risk MDS, relapsed or refractory AML, and emerging cell-therapy approaches in haematological malignancies. He has authored peer-reviewed studies analysing cytogenetic risk in large Korean AML cohorts and has served as responsible party or principal investigator for multiple registered clinical trials. His profile is particularly relevant for patients with complex blood cancers requiring multidisciplinary evaluation and access to transplant or research-based treatment pathways.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an expert opinion from Prof. Je-Hwan Lee at Asan Medical Center, subject to hospital availability and case acceptance.
Why Consider Prof. Je-Hwan Lee?
Prof. Je-Hwan Lee brings together deep clinical experience in leukaemia and bone marrow transplantation with a strong peer-reviewed research record, making him a relevant specialist for patients with complex haematological malignancies.
Areas of Specialisation
Prof. Lee's clinical focus covers acute leukaemia, myelodysplastic syndromes, haematopoietic stem cell transplantation, and cell-based therapies for blood cancers.
Prof. Je-Hwan Lee specialises in the medical management of haematological malignancies, with particular expertise in acute myeloid leukaemia, MDS, and haematopoietic stem cell transplantation. His practice integrates chemotherapy, transplant evaluation, and research-based treatment approaches at Asan Medical Center's Hematologic Cancer & BMT Centre.
Leukaemia & Haematological Malignancies
Comprehensive evaluation and treatment planning for acute and chronic blood cancers.
- arrow_rightAML induction chemotherapy planning, including daunorubicin-based protocols
- arrow_rightCytogenetic and molecular risk stratification for treatment decisions
- arrow_rightManagement of relapsed or refractory AML
- arrow_rightCore-binding factor AML and monosomal karyotype AML
- arrow_rightAssessment and management of higher-risk MDS
- arrow_rightTransplant eligibility evaluation for MDS evolving to AML
- arrow_rightClinical research in post-transplant approaches for higher-risk MDS
Haematopoietic Stem Cell Transplantation
Autologous and allogeneic transplant programmes within a dedicated BMT centre.
- arrow_rightTransplant planning for AML, MDS, and related haematological malignancies
- arrow_rightBusulfan-based and other conditioning regimen selection
- arrow_rightGraft-versus-host disease prophylaxis strategies, including post-transplant cyclophosphamide
- arrow_rightAutologous HCT for core-binding factor AML in eligible patients
- arrow_rightPublished and registered clinical trial experience in autologous HCT outcomes
Cell Therapy & Emerging Approaches
Research-aligned approaches including cell-based strategies and investigational therapies in haematology.
- arrow_rightCell therapy as a listed clinical specialty at Asan Medical Center
- arrow_rightDonor NK-cell therapy approaches in post-transplant settings
- arrow_rightParticipation in phase 1 research evaluating investigational agents in relapsed or refractory AML and MDS
Procedures Performed
Clinical services and treatment approaches in haematological oncology and transplantation
Prof. Je-Hwan Lee's clinical work encompasses haematology-based treatment planning, transplant evaluation and coordination, and research-guided approaches for patients with leukaemia, MDS, and related blood cancers.
AML Induction & Chemotherapy
Medical OncologyEvidence-based chemotherapy planning for newly diagnosed and relapsed AML, informed by cytogenetics, molecular findings, and published treatment protocols.
Haematopoietic Stem Cell Transplantation
TransplantComprehensive transplant evaluation and care, covering donor selection, conditioning intensity, and post-transplant management for eligible patients.
MDS Assessment & Management
Complex DiseaseEvaluation and treatment planning for myelodysplastic syndrome, from risk classification through to transplant decision-making.
Second Opinion โ Blood Cancers
Second OpinionSecond-opinion review for patients with leukaemia, MDS, and related haematological malignancies, coordinated through CancerFax.
Research & Publications
Clinical research and peer-reviewed contributions in haematological oncology
Prof. Je-Hwan Lee has contributed to the haematology literature with studies in AML induction therapy, transplant conditioning, cytogenetic risk, and cell-based approaches for blood cancers. He has also led and participated in registered clinical trials on ClinicalTrials.gov.
Prof. Lee's full publication list and registered clinical trial portfolio may be accessed via PubMed and ClinicalTrials.gov. A more detailed research summary is available on request through CancerFax.
Education & Training
Prof. Je-Hwan Lee completed his undergraduate and postgraduate medical training at Seoul National University and the University of Ulsan, before advancing through residency, fellowship, and successive academic appointments at the University of Ulsan College of Medicine and Asan Medical Center.
Clinical Experience
Prof. Je-Hwan Lee has built his entire academic and clinical career at the University of Ulsan College of Medicine and Asan Medical Center, advancing from Clinical Instructor to his current position as Professor in Hematology within the AMC Cancer Institute and Hematologic Cancer & BMT Centre.
Languages & International
Prof. Je-Hwan Lee's consultation languages have not been publicly verified. CancerFax can arrange professional medical interpreter support for international patients.
CancerFax can coordinate professional medical interpreter support for international patients consulting at Asan Medical Center.
CancerFax can coordinate professional medical interpreter support for international patients when required.
How CancerFax Helps You Access Dr. Je-Hwan Lee
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Je-Hwan Lee's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Je-Hwan Lee's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Je-Hwan Lee before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Je-Hwan Lee's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Je-Hwan Lee's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Je-Hwan Lee's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Je-Hwan Lee
Prof. Je-Hwan Lee is a hematologist specialising in haematopoietic stem cell transplantation, leukaemia, myelodysplastic syndrome, blood diseases, and cell therapy. He practises at Asan Medical Center's Hematologic Cancer & BMT Centre in Seoul, South Korea.
Yes. Acute myeloid leukaemia is one of Prof. Lee's primary clinical and research areas. He has published peer-reviewed studies on AML induction chemotherapy, cytogenetic risk stratification, transplant eligibility, and relapsed or refractory AML, and has led registered clinical trials in AML-related transplantation.
Prof. Lee is based at Asan Medical Center in Seoul, South Korea, one of the country's leading tertiary care and cancer institutions. He works within the Department of Hematology, AMC Cancer Institute, and the Hematologic Cancer & BMT Centre.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Je-Hwan Lee at Asan Medical Center, subject to hospital availability and individual case acceptance. Please submit your reports through CancerFax to initiate the process.
Submit your medical records โ including pathology reports, cytogenetics, bone marrow biopsy results, imaging, and prior treatment history โ through CancerFax. The CancerFax team will review the documents, prepare a structured case summary, and coordinate the next steps with Asan Medical Center, subject to the doctor's availability.
Yes. Prof. Lee has published studies in AML, MDS, and haematopoietic cell transplantation, and is listed as responsible party or principal investigator on ClinicalTrials.gov for studies in autologous HCT for core-binding factor AML and post-transplant cyclophosphamide for higher-risk MDS. His research also includes phase 1 work on investigational agents in relapsed or refractory AML and MDS.
Connect with Je-Hwan Lee Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.